Working… Menu

Study of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in Combination With Gemcitabine/Carboplatin in Patients With Stage IV Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01004731
Recruitment Status : Completed
First Posted : October 30, 2009
Last Update Posted : June 28, 2010
ImClone LLC
Information provided by:
University of Alabama at Birmingham

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 2002
Actual Study Completion Date : January 2006